黑血MRI上的动脉瘤壁强化与未破裂颅内囊状动脉瘤的症状状态独立相关
有症状动脉瘤的AWE面积更大,多因素分析中仅AWE面积为症状的独立相关因素(OR 6.9),其AUC 0.888优于动脉瘤大小(AUC 0.771)。
要点
- 有症状未破裂颅内动脉瘤的AWE面积显著大于无症状者(2.0±0.9 vs 0.4±0.7)。
- AWE面积是症状的独立相关因素(OR 6.9,95%CI 4.0–11.7),AUC 0.888。
- 动脉瘤<10 mm亚组中AWE面积仍为唯一独立危险因素(OR 7.0,p<0.001)。
关键影像表现/征象
- 有症状动脉瘤较无症状者动脉瘤更大(11.2±6.2 mm vs 6.4±3.3 mm)。
- 有症状动脉瘤强化分级更高(1.3±0.6 vs 0.4±0.6)。
- 有症状动脉瘤强化面积更大(2.0±0.9 vs 0.4±0.7)。
- 有症状动脉瘤厚壁强化比例更高(39% vs 3%)。
诊断标准与关键数值
- AWE面积诊断症状的AUC为0.888,敏感度72.2%、特异度92.0%。
- 动脉瘤大小诊断症状的AUC为0.771,敏感度75.9%、特异度65.5%。
- 多因素分析中AWE面积OR 6.9(95%CI 4.0–11.7)。
- 动脉瘤<10 mm亚组(n=118)中AWE面积OR 7.0(p<0.001)。
临床应用与阅片要点
- 黑血MRI增强可评估AWE分级和面积,AWE面积与症状独立相关且诊断效能优于动脉瘤大小。
- 对未破裂颅内囊状动脉瘤,除测量大小外可关注AWE面积,尤其<10 mm动脉瘤。
- 症状包括颅神经 deficits 和头痛,研究提示AWE面积可能为症状评估提供额外信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aims to investigate whether aneurysm wall enhancement (AWE) is independently associated with symptomatic status of unruptured intracranial aneurysms (UIAs).
METHODS: One hundred thirty-nine consecutive patients (67 male, mean age 58 ± 11 years) with 79 symptomatic and 87 asymptomatic UIAs were imaged using black-blood MRI pre- and post-gadolinium contrast administration and 3D DSA. Symptoms related to aneurysms were identified including cranial nerve deficits and headache. AWE grade and area were characterized, and aneurysm size was measured on DSA. Multivariate binary logistic regression analysis was used to identify factors associated with symptoms. Further subgroup analysis was performed for aneurysms size < 10 mm.
RESULTS: Symptomatic UIAs had significantly larger aneurysm size (11.2 ± 6.2 mm vs. 6.4 ± 3.3 mm), enhancement grade (1.3 ± 0.6 vs. 0.4 ± 0.6), enhancement area (2.0 ± 0.9 vs. 0.4 ± 0.7), and higher prevalence of thick enhancement (39% vs. 3%) compared with asymptomatic UIAs, all p < 0.001. In multivariate analysis, only AWE area (odds ratio [OR] 6.9, 95% confidence interval [4.0, 11.7]) was independently associated with symptoms. AWE area had an area under curve (AUC) value of 0.888, with 72.2% sensitivity and 92.0% specificity for symptoms, which was superior to aneurysm size (AUC of 0.771, with 75.9% sensitivity and 65.5% specificity). In the subgroup analysis of aneurysms smaller than 10 mm (n = 118), AWE area (OR, 7.0, p < 0.001) remained the only independent risk factor associated with symptoms.
CONCLUSIONS: Larger AWE area is independently associated with symptomatic UIAs, which may provide additional value to guide UIA management and improve patient outcomes.
KEY POINTS: • Symptomatic intracranial aneurysms are larger and more often demonstrate significant wall enhancement than asymptomatic aneurysms. • Larger wall enhancement area is independently associated with symptomatic intracranial aneurysm.
引用
- Zhu C, Wang X, Eisenmenger L, et al. Wall enhancement on black-blood MRI is independently associated with symptomatic status of unruptured intracranial saccular aneurysm. Eur Radiol. 2020. PMID: 32666320. doi:10.1007/s00330-020-07063-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。